Table 4.
Outcome by Global Cognitive Impairment | n | Unadjusted Cumulative incidence (%) | aHR, aSHR, aIRR* (95% CI) | p-value | ||
---|---|---|---|---|---|---|
6 mo | 1 y | 3 y | ||||
Chance of Listing | ||||||
Overall | ||||||
Not impaired | 233 | 50.5 | 59.1 | 63.8 | 1.00 (reference) | |
Impaired | 3,397 | 32.0 | 43.7 | 51.5 | 0.75 (0.61–0.91) | 0.004 |
Diabetes | ||||||
Not impaired | 1,201 | 52.4 | 63.8 | 69.5 | 1.00 (reference) | |
Impaired | 91 | 42.2 | 57.3 | 65.0 | 0.92 (0.70–1.22) | 0.6 |
No Diabetes | ||||||
Not impaired | 1,682 | 63.8 | 73.3 | 79.8 | 1.00 (reference) | |
Impaired | 93 | 37.9 | 52.9 | 67.7 | 0.63 (0.48–0.83) | 0.001 |
Risk of Waitlist Mortality | ||||||
Overall | ||||||
Not impaired | 2,101 | 0.04 | 1.4 | 9.0 | 1.00 (reference) | |
Impaired | 115 | 0.07 | 2.2 | 14.2 | 1.35 (0.83–2.18) | 0.2 |
Diabetes | ||||||
Not impaired | 793 | 0.7 | 1.9 | 13.5 | 1.00 (reference) | |
Impaired | 56 | 0.6 | 1.8 | 12.7 | 0.90 (0.48–1.70) | 0.8 |
No Diabetes | ||||||
Not impaired | 1,281 | 0.3 | 0.9 | 6.3 | 1.00 (reference) | |
Impaired | 57 | 0.8 | 2.3 | 16.0 | 2.47 (1.31–4.66) | 0.01 |
Rate of KT | ||||||
Overall | ||||||
Not impaired | 2,101 | 6.3 | 17.8 | 42.7 | 1.00 (reference) | |
Impaired | 115 | 4.7 | 13.5 | 33.8 | 0.78 (0.56–1.09) | 0.1 |
Diabetes | ||||||
Not impaired | 793 | 4.3 | 13.0 | 31.5 | 1.00 (reference) | |
Impaired | 56 | 4.5 | 13.7 | 33.0 | 1.12 (0.71–1.77) | 0.6 |
No Diabetes | ||||||
Not impaired | 1,281 | 7.8 | 20.9 | 49.8 | 1.00 (reference) | |
Impaired | 57 | 4.9 | 13.6 | 35.1 | 0.58 (0.36–0.93) | 0.03 |
Participants were classified as cognitively impaired if they had a Modified Mini-Mental State Exam (3MS) score <80. Adjusted associations were controlled for age, sex, race, diabetes, educational attainment, and the Charlson Comorbidity Index adapted for dialysis. To explore the association between each outcome and cognitive impairment by diabetes status, an interaction term was added between cognitive impairment and diabetes status. Abbreviations: HR, hazard ratio; SHR, subdistribution hazard ratio; IRR, incidence rate ratio.
aHR for chance of listing; aSHR for risk of waitlist mortality; IRR for rate of kidney transplantation.